The Global Laboratory Initiative Assisting countries to implement the WHA resolution on MDR-TB Karin Weyer, WHO-STB, GLI secretariat John Ridderhof, CDC,

Slides:



Advertisements
Similar presentations
Stop TB Strategy Planning Frameworks Mukund Uplekar TB Strategy, Operations and Health Systems, Stop TB Department, WHO.
Advertisements

UNDP RBA Workshop on MDG-Based National Development Strategies Module 4: Health Strategies UN Millennium Project February 27-March 3, 2006.
Scaling up the global initiative on the implementation of the SNA and supporting statistics Meeting on Scaling up the coordination and resources for the.
Diseases without borders What must the Global Development Community Do? World Bank Seminar Series Tawhid Nawaz, Operations Advisor Human Development Network.
February 2006 WHO's Contribution to Scaling Up towards Universal Access to HIV/AIDS Prevention, Care and Treatment Department of HIV/AIDS.
An operational package for Integrated Management of HIV/AIDS prevention, treatment and care ICASA - Abuja, Nigeria 5 December 2005.
Technical cooperation with countries Technical Cooperation for essential drugs and traditional medicines September 2005.
Standards and Trade Development Facility (STDF) A joint initiative in SPS capacity building and technical cooperation OIE Global Conference on Veterinary.
THE INTERNATIONAL DRUG PURCHASE FACILITY-UNITAID Michel D. Kazatchkine, Ministère des Affaires Etrangères, France.
The Effectiveness of Global Health Partnerships Findings and Lessons from a World Bank Evaluation of Global Health Programs Uma Lele April 14, 2005.
Karin Weyer WHO Stop TB Department Stop TB Partnership Global Laboratory Initiative.
From DOTS to the Stop TB Strategy Building on Achievements for Future Planning Stop TB Partnership Symposium at the 37 th UNION World Conference on TB.
Improving diagnosis TB laboratory strengthening.
Involving all health care providers in collaborative TB/HIV activities Eva Nathanson PPM subgroup meeting Cairo, Egypt, 3-5 June 2008.
Retooling Task Force. Liquid Media for Culture and Drug Susceptibility Testing Generic checklist for TB Diagnostics developed by Retooling Task Force.
PEPFAR’s Approach to Maximize Efficiency, Effectiveness and Impact
Implementation of Diagnostics in Resource-Limited Settings Amy Piatek Global Health Bureau, Office of Health, Infectious Diseases & Nutrition U.S. Agency.
Overview of the Global Fund: Guiding Principles Grant Cycle / Processes & Role of Public Private Partnerships Johannesburg, South Africa Tatjana Peterson,
Almost 14 years ago all countries endorsed a set of 8 Millennium Development Goals (or MDGs). 3 of those 8 Goals focus on health – that being child mortality,
Compendium of Indicators for Monitoring and Evaluating National Tuberculosis Programs.
USAID TB Technical Assistance Model June 19, 2014.
Tools for HIV/TB Integration and the Civil Society Experience Carol Nawina Nyirenda Executive Director Community Initiative for Tuberculosis, HIV/AIDS.
African Business Leaders on Health GBC Conference on TB, HIV-TB Co-infection & Global Fund Partnership Johannesburg, October 2010 Technical Assistance.
Unit 9. Human resource development for TB infection control TB Infection Control Training for Managers at National and Subnational Level.
Total health ODA commitments, US$ Billions.
Cross Border Animal Health Plan of Action – Kenya and Uganda Four Strategic areas 1. To improve prevention, management and control of cross border animal.
Biosafety and Biosecurity Challenges in the Caribbean Region Valerie Wilson Caribbean Med Labs Foundation Anticipating Global Biosecurity Challenges Istanbul,
DOTS Expansion Working Group Meeting Engaging Professional Associations in TB Control Paris, 15 October 2008 Dr J.M. Chakaya Chair, DEWG.
Prevention and Control of Viral Hepatitis Infection: WHO Framework for Global Action Prevention and Control of Viral Hepatitis Infection: WHO Framework.
Ibero-American Road Safety Conference Madrid, February 23-24, World Bank Global Road Safety Facility.
TB and community systems strengthening October 1, Oct 2013Geneva.
Update of the Global Plan to Stop TB TB/HIV Working Group Meeting Geneva, November 2009 Christian Lienhardt.
Existing Challenges – POC Introduction Lab Technical Working Group Jason Williams, Principal Laboratory Advisor, SCMS January 20-21, 2013.
WHO-HIV Department Strategic Information Unit AIDS Medicines and Diagnostics Service Contribution to Access to medicines Technical Briefing Seminar, November.
Regional Strategy on Human Resources for Health (WHO Western Pacific Region) Presentation by Dr Ezekiel Nukuro Regional Adviser, Human Resources.
DEWG Meeting Geneva 14 October 2009 TB in children Report from the breakout session.
1 DEWG meeting October 2009 Human Resource Development for TB Control (HRD-TB) Sub Group within the DEWG of the Stop TB Partnership. Wanda Walton.
1 Pharmaceutical System Strengthening: Is There a Need for a New Paradigm? Douglas Keene, PharmD, MHS ICIUM-3 Pre-Conference Session 14 November 2011.
World Health Organization "3 by 5" Target Treat 3 million by 2005.
Philippe Duneton11 February 2009 Deputy Executive Secretary 5th Consultative Stakeholder Meeting UN Prequalification of Diagnostics, Medicines & Vaccines.
TBS 2008-H. Tata & M. Babaley Mapping and In-depth Assessment of Medicines Procurement and Supply Systems WHO Technical Briefing Seminar 17 th -21 st November.
Consultant Advance Research Team. Outline UNDERSTANDING M&E DATA NEEDS PEOPLE, PARTNERSHIP AND PLANNING 1.Organizational structures with HIV M&E functions.
Report of the 2nd ad hoc Committee on the TB epidemic Jaap F. Broekmans STOP TB Partner’s Forum NEW DELHI June 2004.
Scaling-up HIV Prevention, Care and Antiretroviral Therapy at Primary Health Centers A WHO/PEPFAR Collaboration.
TB infection control and prevention of XDR Group II.
Pharmacovigilance in HIV/AIDS Public Health Programmes: Luxury or Priority? November 2009, dar Es Salaam.
1.1.Recovery strategic planning capacities are strengthened. 1.2.Local capacity for ER planning and implementation strengthened in areas of expertise where.
HIV TESTING AND EXPANSION OF ART FOR TB PATIENTS, BOTTLE NECKS CHALLENGES AND ENABLERS FOR SCALE UP IN KENYA DR. JOSEPH SITIENEI, OGW NTP MANAGER - KENYA.
Public health, innovation and intellectual property 1 |1 | The Global Strategy on Public Health, Innovation and Intellectual Property Technical Briefing.
The Bank’s Regional HIV/AIDS Strategies An Overview.
Implementing operational research for HIV treatment scale-up in resource-limited settings TB/HIV Research Priorities in Resource-Limited Settings Expert.
3rd WHO Prequalification Stakeholders Meeting :Diagnostics 3rd Stakeholders Meeting on Prequalification Geneva, 4th February 2008 Update on Prequalification.
1 Introducing the ARC: The New Performance Appraisal Tool for RCs and UNCTs March 2016.
Role of WHO as Technical Advisor to Ministry of Health West Bank and Gaza.
THE GLOBAL FUND SUSTAINING THE GAINS AND IMPACT Uganda November 2013.
WHO Estonia country office Marge Reinap Head of WHO Country Office in Estonia.
Compendium of Indicators for Monitoring and Evaluating National Tuberculosis Programs.
Outline The Global Fund Strategy emphasizes the Key Populations
The New Performance Appraisal Tool for RCs and UNCTs
Overview of guidance/frameworks
WHO’s prioritised research agenda for the prevention and control of NCDs prioritises
Stop TB Partnership Secretariat (TBP)
Stop TB Partnership Secretariat (TBP) M. Espinal, Executive Secretary
Objectives of Session Provide an overview of the development of Compendium Explain the organization of the Compendium and how indicators are used Provide.
Access to HIV/AIDS Medicines The 3x5 strategy
Conclusions and recommendations – first draft
TB Strategy & Health Systems (TBS) TB Monitoring & Evaluation (TME)
5th DEWG meeting Conclusions
Supporting Implementation of the EDL
The STOP TB Strategy – 2009 VISION: A TB-free world
Presentation transcript:

The Global Laboratory Initiative Assisting countries to implement the WHA resolution on MDR-TB Karin Weyer, WHO-STB, GLI secretariat John Ridderhof, CDC, GLI chair TB/HIV Core Group meeting Geneva, November 3-4, 2009

Global Laboratory Initiative Platform of coordination and communication, providing the required infrastructure, focused on TB laboratory strengthening, in the areas of: Global policy guidance (norms, standards, best practices) Laboratory capacity development Interface with other laboratory networks, enabling integration Standardised laboratory quality assurance Coordination of technical assistance Effective knowledge sharing Advocacy and resource mobilisation

GLI structure & governance GLI Secretariat GLI Partners Committee GLI Core Group Stop TB Partnership Laboratory strengthening roadmap Human resource development strategy Laboratory biosafety Laboratory accreditation Other Evaluates, approves, governs projects; Advises GLI Secretariat Advises and approves strategic agenda of GLI; Monitors project progress WHO Stop TB Department Priority projects and activities Time limited Partner approach Technical Working Groups GLI Secretariat GLI Working Group

GLI Network ~ smear lab centers personnel ~8.000 advanced diagnostic centers – personnel 28 SRLs supporting 150 NRLs >70 GLI Members WHO GLI Office Knowledge sharing -Coordinating TA, training -Communication technologies - Online knowledge resource network Interface connection -Matchmaking projects between countries and implementing partners -National “roadmaps” -Advocacy -Other disease networks Assurance activities - Coordination of EQA -Equipment specifications -Global accreditation system -Monitoring/evaluation Guidance -Laboratory policies -Laboratory manuals -Training materials -Resource mobilization -National roadmap advice Key GLI activities Capacity building (expanding SRLN, building diverse and flexible national, regional, international consultants base, systematic and structured training) 7 STP WGs Technical Agencies Other Laboratory Networks Other Diseases

GLI strategic priorities Accelerating evidence-based policy development on diagnostics and laboratory practices Promoting a structured framework/roadmap for TB laboratory strengthening within the context of national laboratory plans at country level Developing a comprehensive set of tools, norms and standards based on international standards and best- practice Advancing laboratory strengthening through global, regional and local partnerships Developing multi-level laboratory human resource strategies to address the capacity crisis Accelerating new diagnostics into countries

Accelerated uptake of new MDR-TB diagnostics in 27 countries, (additional 15 planned by 2012) State-of the-art commodities (instruments, tests, reagents) funded by UNITAID Leverage other local partners to address non-commodity components (infrastructure, training, etc.) Long-term mentoring and TA: in-country hands-on support to optimise technology and knowledge transfer, closely linked to capacity building Full ownership of MOH, NTP, Laboratory Integrated laboratory approach (notably TB and HIV) Adjustment based on growing evidence ('learning by doing')

Policies, norms international standards Participate in lab assessments Provide long-term, on-site monitoring Develop indicators and tools for M&E Funding for essential instruments, reagents, supplies Negotiate with partners to ensure lowest prices Ensure customer support in place Share know-how from product development process Provide long-term, on-site mentoring for technology transfer Coordinate and manage procurement and delivery With FIND, engage industry to ensure affordability and sustained price decreases Collaborate with WHO Pre-qualification to include diagnostics

8 Category 1: start in 2009 Category 2: start in 2010 Category 3: start in 2011 Recipient countries

Countries Total * Targets calculated as a % of estimated MDR-TB burden: 80% for most countries; 35% for India and 60% for Zambia and Cameroon

Country partners American Society for Microbiology Centers for Disease Control and Prevention Johns Hopkins University GHESKIO Global AIDS Programme GTZ KfW Bank, Germany KNCV Ministeries of Health, through NTPs Partners in Health PEPFAR OGAC Project Hope ICRC The Global Fund The Union USAID WHO Supranational Reference Laboratory Network …

Future scale-up EXPAND-TB –15 additional countries by 2012 Other low-income, high-endemic countries –Adoption of EXPAND-TB model with other funding sources and other laboratory initiatives (eg. HIV, Malaria, H1N1) Middle-income, high-endemic countries –Two-pronged approach (manufacturers and laboratory networks) in innovative PPM models Acceleration of GLI human resource development plan –At least 50 global consultants –At least 50 long-term, on-site mentors –Up to 20,000 laboratory technicians with advance skills –MOH responsibilities in revised human resource plans & strategies

Global targets met for MDR-TB patients diagnosed and provided with appropriate treatment under international standards of care Diagnostics Drugs Patient care